The role of patient and public voice members on the UK NSC
Find out more about the role of the UK NSC's patient and public voice members (PPVs) and the essential contribution they make to the work of the committee.
Search results for about
Why evidence maps are the UK NSC’s first step in reviewing screening evidence
Using evidence maps as the first stage in its evidence review process helps the UK NSC focus its more detailed work on topics where there is the most significant new evidence.
UK NSC screening manual describes best practice for national screening programmes
The new UK NSC screening manual sets out the evidence base, policy requirements, implementation processes, quality assurance requirements and core pathway components needed for national screening programmes.
Updated UK NSC evidence review guidance and processes
The UK NSC has published a new collection of documents on GOV.UK that describe its processes and principles for implementing the chief medical officers’ recommendations for the committee’s expanded remit.
UK NSC recommends introduction of targeted lung cancer screening
The UK NSC has recommended that the 4 UK nations should move towards implementing a targeted national lung cancer screening programme, integrated with smoking cessation services.
Annual call has opened: suggest a new screening programme or changes to a current programme
The 2022 annual call has opened for submission of proposals for potential new screening programmes or new technologies that have not previously been reviewed by the UK National Screening Committee.
Bursaries available for popular health screening course
A small number of bursaries are now available for the ever-popular Warwick health screening module.
Prepare your screening submissions for the 2022 annual call
Next month, the UK NSC will once again open its annual call process when any individual or organisation can suggest a new screening programme. Following the expansion of the committee’s remit, the UK NSC will welcome proposals for targeted and stratified screening as well as population screening.
Nearly one third of a million babies screened for SCID already
More than 300,000 babies in England have already been screened for severe combined immunodeficiency in an evaluation run by the UK NSC and NHS England.
Guidance on evaluating AI for use in breast screening
Find out more about the new Lancet Digital Health article on the UK NSC approach to reviewing evidence on AI in breast screening.